Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Scientific Officer sold 17,535 shares at $15.02 ($263,300)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Scientific Officer sold 600 shares at $15.00 ($9,000)
  8. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $20.32 ($230,292)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Other disposition Director disposed of 400,000 shares (other)
  16. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $20.00 ($226,626)
  17. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $20.73 ($234,985)
  18. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $24.19 ($274,171)
  19. 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $27.37 ($310,155)
  20. 4 Open-market sale Chief Financial Officer sold 3,900 shares at $27.00 ($105,300)

Page 14 of 20 · 399 filings